Mostrando 10 resultados de: 16
Filtros aplicados
Publisher
Journal of Clinical Rheumatology(5)
Clinical Rheumatology(4)
Autoimmunity Reviews(2)
Annals of the Rheumatic Diseases(1)
Antibodies(1)
Área temáticas
Enfermedades(11)
Medicina y salud(10)
Cirugía y especialidades médicas afines(1)
Fisiología humana(1)
Problemas sociales y servicios a grupos(1)
Área de conocimiento
Inmunología(4)
Medicina interna(3)
Salud pública(2)
Cuidado de la salud(1)
Farmacología(1)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(15)
ODS 10: Reducción de las desigualdades(11)
ODS 17: Alianzas para lograr los objetivos(10)
ODS 12: Producción y consumo responsables(2)
ODS 1: Fin de la pobreza(2)
Origen
scopus(16)
Correction to: PANLAR consensus statement on biosimilars (Clinical Rheumatology, (2019), 38, 5, (1485-1496), 10.1007/s10067-019-04496-3)
OtherAbstract: The two co-authors of the mentioned above article were incorrect. The correct are authors should havPalabras claves:Autores:Avila-Pedretti G., Azevedo V.F., Babini A.M., Beltrán P.A., Benavides J.A., Caballero-Uribe C.V., Cachafeiro-Vilar A., Cifuentes-Alvarado M., Claudio M. Galarza-Maldonado, Cohen S.B., Díaz P.E., Díaz-Coto J.F., Encalada C., Firedman D.X.X., Garro B., Guibert-Toledano M., Kay J., Kowalski S.C., Lopez M.E.L., Mysler E., Ortega A.P., Pineda-Villaseñor C., Rodriguez V.J.K., Russell A.S., Santos-Moreno P., Sariego I.A.G., Soriano E.R., Terán I.S., Vargas A., Vásquez G., Xavier R.M.Fuentes:scopusCurrent trends for biosimilars in the Latin American market
ArticleAbstract: The number of approved biological medicines in the global pharmaceutical market has increased in recPalabras claves:Biologicals, biopharmaceuticals, Biosimilars, Latin AmericaAutores:Claudio M. Galarza-Maldonado, Dámaris P. Intriago-Baldeón, Diana C. Checa-Jaramilloz, Diana Castillo, Esteban Ortiz-Prado, Felipe Andrade, Jorge Eduardo Vásconez, Nathalia Rodríguez-Burneo, Ponce-Zea J.Fuentes:scopusInfections and the antiphospholipid syndrome
ReviewAbstract: Currently, the origin of autoimmune diseases is considered to be multifactorial. Genetic predispositPalabras claves:Anticardiolipin, Antiphospholipid, infection, ThrombosisAutores:Cervera R., Claudio M. Galarza-Maldonado, Escárcega R.O., García-Carrasco M., Mendoza-Pinto C.Fuentes:scopusThe HELLP syndrome, antiphospholipid antibodies, and syndromes
OtherAbstract:Palabras claves:Autores:Asherson R., Claudio M. Galarza-Maldonado, Sanin-Blair J.Fuentes:scopusThe administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus
ReviewAbstract: Background: In Latin America, the medical attention directed to systemic autoimmune diseases competePalabras claves:Autores:Cardiel M.H., Cervera R., Claudio M. Galarza-Maldonado, Doukh N., Kourilovitch M.R., Molineros J.E., Soroka N.F., Yagur V.Y., Zurita L.Fuentes:scopusTherapeutic Guidelines for Latin American Lupus Patients: Methodology
ArticleAbstract:Palabras claves:Autores:Acevedo-Vásquez E.M., Alarcón G.S., Amigo Castañeda M.C., Barile-Fabris L.A., Bonfá E.S.D.D.O., Cardiel M.H., Catoggio L.J., Chacón-DÍaz R., Claudio M. Galarza-Maldonado, Duarte M., Espada G., García M.A., Iglesias Gamarra A.J., Izcovich A., Levy R.A., Massardo L., Molina Restrepo J.F., Neira O., Pons-Estel B.A., Sato E.I., Silva C.A., Soriano E.R., Vargas Peña A., Vásquez G.Fuentes:scopusNeutrophil extracellular traps, antiphospholipid antibodies and treatment
ReviewAbstract: Neutrophil extracellular traps (NETs) are a network of extracellular fibers, compounds of chromatin,Palabras claves:Antibodies, Antiphospholipid syndrome, Autophagy, NETosis, Neutrophil extracellular trapsAutores:Bravo-Barrera J., Claudio M. Galarza-Maldonado, Kourilovitch M.R.Fuentes:scopusTreating rheumatoid arthritis to target: Multinational recommendations assessment questionnaire
ArticleAbstract: Aim: To measure the level of agreement and application of 10 international recommendations for treatPalabras claves:Autores:Aletaha D., AlShehhi W.Y., Awadhi A.A., Babic-Naglic D., Breedveld F.C., Burmester G., Cardiel M.H., Claudio M. Galarza-Maldonado, Codreanu C., Da Silva J.P., De Morales S.V., De Wit M., Dougados M., Durez P., Emery P., Fonseca J.E., Gibofsky A., Gomez-Reino J., Graninger W., Hammoudeh M., Hamuryudan V., Haraoui B., Harrison M., Kalden J., Kolarov Z., Kvien T.K., Laurindo I.M., Lee S.K., Martin-Mola E., Michel B.A., Montecucco C., Moreno P.S., Nash P., Otsa K., Pavelka K., Peña M.J.J., Poor G., Smolen J.S., Sokka T., Stanislawska-Biernat E., Takeuchi T., Tate G.A., Tomsic M., Uthman I., Van Der Heijde D., Venalis A.Fuentes:scopusUse of rituximab for the treatment of rheumatoid arthritis: The Latin American context
ArticleAbstract:Palabras claves:Anti-CD20 antibody, Biologic therapy, Latin America, Rheumatoid Arthritis, rituximab, Treatment guidelinesAutores:Achurra-Castillo A.F., Alarcón G.S., Barile-Fabris L.A., Caballero-Uribe C.V., Cardiel M.H., Chávez-Corrales J.E., Claudio M. Galarza-Maldonado, Díaz-Coto J.F., Esteva-Spinetti M.H., Guibert-Toledano M., Keiserman M.W., Lomonte A.V., Massardo L., Mota L.M.H., Palazuelos I.F., Pineda-Villaseñor C., Pons-Estel B.A., Soriano E.R.Fuentes:scopusUse of rituximab in patients with systemic lupus erythematosus: An update
ReviewAbstract: Systemic lupus erythematosus (SLE) is a chronic, occasionally life threatening, multisystem disorderPalabras claves:Autores:Cervera R., Claudio M. Galarza-Maldonado, Escárcega R.O., García-Carrasco M., Jiménez-Hernández M., López-Colombo A., Mendoza-Pinto C., Sandoval-Cruz M., Zamudio-Huerta L.Fuentes:scopus